| Previous issue |  > Previous issue |
|
|
|
|
|
|
73 |
Therapeutic Options in High-Risk Nonmuscle Invasive Bladder Cancer During the Shortage of Bacillus Calmette-Guérin
Jeongwan Yoo, Yeon Joo Kim, Bum Sik Tae, Jae Young Park
Korean J Urol Oncol. 2020;18(2):73-77. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.73
|
|
|
|
|
78 |
Epigenetic Approaches to the Treatment of Renal Cell Cancer
Seong Hwi Hong, Jiyoung Lee, Eun Bi Jang, Sung Yul Park, Hong-Sang Moon, Young Eun Yoon
Korean J Urol Oncol. 2020;18(2):78-90. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.78
|
|
|
|
|
91 |
Approaches for Personalized Drug Development in Bladder Cancer Patients
Hyang Sook Seol, In Ho Chang
Korean J Urol Oncol. 2020;18(2):91-98. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.91
|
|
|
|
|
99 |
New Androgen Receptor Axis-Targeted Agents in the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer: From Bench to Clinical Trials
Jeong Hee Hong
Korean J Urol Oncol. 2020;18(2):99-108. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.99
|
|
|
|
|
|
|
109 |
Risk Factors for pT3a Prostate Cancer in the Patients With cT1-2 on Preoperative Multiparametric Magnetic Resonance Imaging
Kyung Hwan Kim, Ja Yoon Ku, Won Young Park, Seung Baek Hong, Suk Kim, Hong Koo Ha
Korean J Urol Oncol. 2020;18(2):109-115. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.109
|
|
|
|
|
116 |
Serum Testosterone Level Can Be Predictive Factor for Upstaging in Clinically Localized Prostate Cancer
Soon Oh Kwon, Kyeong-Hyeon Byeon, Jae-Wook Chung, Yun-Sok Ha, Seock Hwan Choi, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Ghil Suk Yoon, Jun Nyung Lee, Tae Gyun Kwon
Korean J Urol Oncol. 2020;18(2):116-123. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.116
|
|
|
|
|
124 |
Management of Patients With Advanced Prostate Cancer: Establishment of Treatment Guidelines Through Prostate Cancer Summit (PCAS) 2016 Composed of Korean Prostate Cancer Experts
Chun Tae Jang, Hyung Joon Kim, Myung Ki Kim, Sung Woo Park, Seung Chol Park, Jae Young Park, Dong Hyeon Lee, Seung Hwan Lee, Hwang Gyun Jeon, Jae Hoon Chung, Hyeon Jeong, Moon Ki Jo, Sung-Hoo Hong, Cheol Kwak, Ji Youl Lee, Dong Deuk Kwon, Choung-Soo Kim, Seong Soo Jeon
Korean J Urol Oncol. 2020;18(2):124-139. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.124
|
|
|
|
|
140 |
Estramustine Phosphate Monotherapy in Castration-Resistant Prostate Cancer Patients Who Cannot Receive Cytotoxic Chemotherapy
Jae Hyun Ryu, Sang Jin Kim, Yun Beom Kim, Tae Young Jung, Kyong Tae Moon, Jeong Man Cho, Tag Keun Yoo
Korean J Urol Oncol. 2020;18(2):140-146. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.140
|
|
|
|
|
147 |
Potential Utility of Prostate Health Index Density for Prostate Cancer Detection and Prediction in Korean Men: A Prospective Multicenter Study
Geehyun Song, Hongzoo Park, Sang Wook Lee, Tae Wook Kang, Jae Hung Jung, Hyun Chul Chung, Sung Jin Kim, Jong Yeon Park, Jeong Hyun Kim
Korean J Urol Oncol. 2020;18(2):147-154. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.147
|
|
|
|
|
|
|
155 |
Open Partial Nephrectomy With Zero Ischemia Technique Using Thulium Laser: Our Experience of 4 Cases
Kumar Prem, Pankaj Kumar, Zia Ur Rehman, Somesh Janoria
Korean J Urol Oncol. 2020;18(2):155-160. Published online August 27, 2020 DOI: https://doi.org/10.22465/kjuo.2020.18.2.155
|
|
|
|
|
|
|
